MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, anrease of 23.3% over]

MR [Mindray Medical International] CORRESP: (Original Filing)

[July 27, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Mindray Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the “]

MR [Mindray Medical International] CORRESP: July 27, 2012 Mr. Martin James Senior Assistant

[July 27, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Mindray Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the “]

MR [Mindray Medical International] CORRESP: (Original Filing)

[July27, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 STYLE="font-family:Times New Roman" SIZE="2"> Filed April30, 2012 File No.001-33036 STYLE="font-family:Times New Roman" SIZE="2"> Dear Mr.James:mpany Mindraymment Letter 2011 Form20-F]

MR [Mindray Medical International] CORRESP: July27, 2012 Mr.Martin James Seniorsistant Chief Accountant Division

[July27, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 STYLE="font-family:Times New Roman" SIZE="2"> Filed April30, 2012 File No.001-33036 STYLE="font-family:Times New Roman" SIZE="2"> Dear Mr.James:mpany Mindraymment Letter 2011 Form20-F]

MR [Mindray Medical International] CORRESP: Confidential Treatment Requested By Mindray Medical International Limited

[Confidential Treatment Requested By Mindray Medical International Limited In accordance with Rule 83, this letter hasso been clearly marked with the legendnfidential Treatment Requested by Mindray Medical International Limited and each page is marked for the record with the identifying numbers andde M-1 through M-14. Mindray responds to themment Letter follows:]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Completes Acquisition of Dragonbio’s Orthopedics Business About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network]

MR [Mindray Medical International] 6-K: Mindray Medical Completes Acquisition of Dragonbio’s Orthopedics Business

[Mindray Medical Completes Acquisition of Dragonbio’s Orthopedics Business About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network]

MR [Mindray Medical International] 6-K: Mindray Medicalmpletes Acquisition of Dragonbios Orthopedics Business STYLE=”font-family:Times

[Mindray Medicalmpletes Acquisition of Dragonbios Orthopedics Business STYLE="font-family:Times New Roman" SIZE="2">out Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters inShenzhen, China, U.S. headquarters inMahwah, New Jerseyand multipleles offices in major international markets. From our main manufacturing and engineering basehina, we supply through our worldwide distribution]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medicalmpletes Acquisition of Dragonbios Orthopedics Business STYLE="font-family:Times New Roman" SIZE="2">out Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters inShenzhen, China, U.S. headquarters inMahwah, New Jerseyand multipleles offices in major international markets. From our main manufacturing and engineering basehina, we supply through our worldwide distribution]

Skip to toolbar